IMMNOV — Immunovia AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK84.33m
- SEK41.94m
- SEK1.58m
Annual cashflow statement for Immunovia AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -114 | -134 | -167 | -191 | -296 |
| Depreciation | |||||
| Non-Cash Items | 8.44 | 0.182 | 0.985 | 23.5 | -1.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 13.9 | 3.69 | -6.07 | -7.9 | 8.88 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -92 | -121 | -153 | -176 | -147 |
| Capital Expenditures | -36.6 | -47.5 | -24.2 | -1.62 | -1.06 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0.537 | 0.358 | 0 | 4.26 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -36.6 | -47 | -23.8 | -1.62 | 3.2 |
| Financing Cash Flow Items | 0.291 | 0 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.76 | 374 | -5.27 | -5.11 | 115 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -123 | 205 | -181 | -181 | -29.3 |